Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2015-10-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acupuncture in Chemotherapy-induced Peripheral Neuropathy in Women With Breast Cancer
NCT05673746
The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN).
NCT02309164
Efficacy of Acupuncture on Chemotherapy-Induced Peripheral Neuropathy (CIPN)
NCT04651907
Efficacy of Acupuncture on Chemotherapy-Induced Peripheral Neuropathy
NCT04739631
"Electro Acupuncture in the Treatment and Management of Chemotherapy Induced Peripheral Neuropathy"
NCT02821442
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acupuncture
Acupuncture including scalp needling will be applied to selected points based on literature
Acupuncture
Acupuncture twice a week for 6 weeks then one treatment a week for 4 weeks. Total 16 treatments in 10 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acupuncture
Acupuncture twice a week for 6 weeks then one treatment a week for 4 weeks. Total 16 treatments in 10 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Currently receiving neurotoxic chemotherapy
3. Experiencing symptoms of chemotherapy induced neuropathy for at least 1 month
4. Have a minimum score of 3 on the VAS should have a grade II CIPN on NCICTC
5. Willing to sign an informed consent
6. Stable treatment for more than two months before screening
* Stable treatment is defined as no change in the type and dose of medications 2 months prior to enrollment.
* Once enrolled, the patients will be asked to remain on the same type and dose of the medications for neuropathy
Exclusion Criteria
2. Pre-existing peripheral neuropathy due to any other cause than chemotherapy
3. Pre-existing conditions like pregnancy, uncontrolled diabetes, hypertension, cardiovascular disorders, bleeding disorders, depression (BDI \> 21)
4. Unwilling to follow the protocol
5. Individuals who are receiving government disability assistance
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Southern California University of Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sivarama Vinjamury
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sivarama Vinjamury, MD, MAOM
Role: PRINCIPAL_INVESTIGATOR
Southern California University of Health Sciences, College of Eastern Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Southern California University of Health Sciences
Whittier, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VINJ007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.